Ajanta Pharma share news, announcements and annual reports
NSE: AJANTPHARMBSE: 532331Pharmaceuticals & BiotechnologyMid Cap
Ajanta Pharma Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 2000 on NSE, Jun 2000 on BSE
Last close ₹3,508.80up ₹49.10 (1.42%)BSE ₹3,512.40
Share price at the NSE close on 30 Oct 2026. Previous close ₹3,459.70.
30 Oct: open ₹3,479.00, high ₹3,619.90, low ₹3,460.50
52-week range of traded prices to 30 Oct 2026
₹2,430.00Low, 30 Oct 2025₹3,796.00High, 18 Aug 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹43,846 Cr236th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 34.72
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 9.02
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.71%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 27.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 30.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.02
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 9,52,55826.6% delivered
Ajanta Pharma share news and announcements
812 announcements, routine notices left out, newest first. Page 11 of 17.
Oct 2015
Aug 2015
Jul 2015
6 Jul · Disclosure of Voting Pattern - Clause 35A
Jun 2015
May 2015
25 May · Code of Conduct under SEBI(PIT) Reg., 2015
8 May · Dividend
Board of Directors of the Company at its meeting held on May 8, 2015, have recommended dividend @ Rs. 6/- per equity share on the face value of Rs. 2/- each, subject to approval of shareholders at the ensuing Annual General Meeting to be held in 2015.
Apr 2015
24 Apr · Board meeting
To inter alia: 1. Consider and approve the audited Financial Results of the Company for the quarter and year ended March 31, 2015; 2. Consider and approve Financial Statements for the year ended March 31, 2015 3. Recommend dividend, if any, on equity shares of the Company for the financial year 2014-15.
Mar 2015
11 Mar · Disclosure of Voting Pattern - Clause 35A
Feb 2015
Jan 2015
28 Jan · Corporate action
At the Board meeting held on January 28,2015, the Board has: Approved sub-division of nominal value of equity shares of the Company from Rs. 5/- each to nominal value of Rs. 2/- each and consequential amendment to the Memorandum of Association and Articles of Association, subject to approval of Members of the Company to be taken by postal ballot.
Oct 2014
16 Oct · Board meeting
To consider and approve, inter alia, the Unaudited Financial Results for the second quarter and half year ended 30th September, 2014.
Aug 2014
6 Aug · Disclosure of Voting Pattern - Clause 35A
Jul 2014
21 Jul · Board meeting
To consider and approve, inter alia, the Unaudited Financial Results for the first quarter ended June 30, 2014.9 Jul · Dividend
Subject to approval of the shareholders at the forthcoming Annual General Meeting, the date of payment of dividend on equity shares would be on or after August 05, 2014.
Jun 2014
12 Jun · Board meeting
For considering appointment of two Additional Directors of the Company.10 Jun · Meeting
Company shall close its Equity Share Transfer Books for a period from July 28, 2014 to August 05, 2014 (both days inclusive) for the purpose of dividend. Further, the Annual General Meeting of the Company is scheduled to be held on August 05, 2014.
May 2014
5 May · Dividend
Board of Directors of the Company at its meeting held on May 05, 2014 have recommended dividend @ Rs.10/-per equity share on the face value of Rs.5/- each, subject to approval of shareholders at the ensuing Annual General Meeting to held in 2014.5 May · Business
Compensation Committee of Directors at its meeting held on May 05, 2014, has allotted 17,800 fully paid up equity shares of Rs. 5/- each and 8,900 bonus shares thereon in the ratio of 1:2. These shares have been allotted upon exercise of options granted to the employees under Employees Stock Option Scheme 2011 of the Company.In view of the above, the issued and paid up capital of the Company shall be increased to Rs. 17,58,87,000 consisting 3,51,77,400 equity shares of Rs. 5/- each.